Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes.

Autor: Dimitrakopoulos FI; Division of Oncology, University Hospital of Patras 'Panagia the Help', University of Patras, Patras, Greece; Molecular Oncology Laboratory, Department of Medicine, University of Patras, Patras, Greece. Electronic address: fodimitrakopoulos@upatras.gr., Goussia A; Department of Pathology, Ioannina University Hospital, Ioannina, Greece; Department of Pathology, German Oncology Center, Limassol, Cyprus., Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece., Dadouli K; Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece., Batistatou A; Department of Pathology, Ioannina University Hospital, Ioannina, Greece., Kourea HP; Department of Pathology, University Hospital of Patras, Rion, Greece., Bobos M; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece; Department of Biomedical Sciences, School of Health Sciences, International Hellenic University, Thessaloniki, Greece., Arapantoni-Dadioti P; Department of Pathology, Henry Dunant Hospital, Athens, Greece., Tzaida O; Department of Pathology, Metaxas Cancer Hospital, Piraeus, Greece., Koletsa T; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece., Chrisafi S; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece., Sotiropoulou M; Department of Pathology, Alexandra Hospital, Athens, Greece., Papoudou-Bai A; Department of Pathology, Ioannina University Hospital, Ioannina, Greece., Nicolaou I; Department of Histopathology, Agii Anargiri Hospital, Athens, Greece., Charchanti A; Department of Anatomy-Histology-Embryology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece., Mauri D; Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Greece., Aravantinos G; Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece., Binas I; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Res E; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece., Psyrri A; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Pectasides D; Oncology Section, Second Department of Internal Medicine, Hippokratio Hospital, Athens, Greece., Bafaloukos D; First Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Koumarianou A; Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Greece., Bompolaki I; Oncology Department, General Hospital of Chania, Crete, Greece., Rigakos G; Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece., Karanikiotis C; Department of Medical Oncology, 424 Army General Hospital, Thessaloniki, Greece., Koutras A; Division of Oncology, University Hospital of Patras 'Panagia the Help', University of Patras, Patras, Greece., Zagouri F; Department of Clinical Therapeutics, Alexandra Hospital, National Andistrian U Kapodniversity of Athens School of Medicine, Athens, Greece., Gogas H; First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece; Aristotle University of Thessaloniki, Thessaloniki, Greece; Department of Medical Oncology, German Oncology Center, Limassol, Cyprus.

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2024 Feb; Vol. 73, pp. 103668. Date of Electronic Publication: 2023 Dec 25.

ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer

Autor: Koumarianou, A. Makrantonakis, P. Zagouri, F. Papadimitriou, C. Christopoulou, A. Samantas, E. Christodoulou, C. Psyrri, A. Bafaloukos, D. Aravantinos, G. Papakotoulas, P. Baka, S. Andreadis, C. Alexopoulos, A. Bompolaki, I. Kampoli, Κ. Liori, S. Karvounis, K. Ardavanis, A.

Purpose: The efficacy of nab-paclitaxel in patients with metastatic breast cancer (MBC) has been demonstrated in randomized clinical trials. However, real-world evidence on effectiveness remains limited. Patients and methods: The primary objective of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::960901e613ba9a45595726528efbb3ff
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078797

Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy-A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study.

Autor: Spathas N; Fourth Oncology Department, Metropolitan Hospital, 18547 Athens, Greece., Goussia AC; Department of Pathology, Ioannina University Hospital, 45500 Ioannina, Greece., Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, 11526 Athens, Greece., Gogas H; First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, 11527 Athens, Greece., Zagouri F; Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, 11528 Athens, Greece., Batistatou A; Department of Pathology, Ioannina University Hospital, 45500 Ioannina, Greece., Charchanti AV; Department of Pathology, Ioannina University Hospital, 45500 Ioannina, Greece., Papoudou-Bai A; Department of Pathology, Ioannina University Hospital, 45500 Ioannina, Greece., Bobos M; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece., Chrisafi S; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece., Chatzopoulos K; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece., Kostopoulos I; Department of Pathology, School of Health Sciences, Faculty of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece., Koletsa T; Department of Pathology, School of Health Sciences, Faculty of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece., Arapantoni P; Department of Pathology, Henry Dunant Hospital, 11526 Athens, Greece., Pectasides D; Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, 11527 Athens, Greece., Galani E; Second Department of Medical Oncology, Metropolitan Hospital, 18547 Piraeus, Greece., Koutras A; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, 26504 Patras, Greece., Zarkavelis G; Department of Medical Oncology, Medical School, University of Ioannina, 45500 Ioannina, Greece., Saloustros E; Department of Oncology, University Hospital of Larissa, 41334 Larissa, Greece., Bafaloukos D; First Department of Medical Oncology, Metropolitan Hospital, 18547 Piraeus, Greece., Karanikiotis C; Department of Medical Oncology, 424 Army General Hospital, 56429 Thessaloniki, Greece., Bompolaki I; Oncology Department, General Hospital of Chania, 73300 Crete, Greece., Aravantinos G; Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, 14564 Athens, Greece., Psyrri A; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, 12462 Athens, Greece., Razis E; Third Department of Medical Oncology, Hygeia Hospital, 15123 Athens, Greece., Koumarianou A; Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, 12462 Athens, Greece., Res E; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, 14564 Athens, Greece., Linardou H; Fourth Oncology Department, Metropolitan Hospital, 18547 Athens, Greece., Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.; Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.; Department of Medical Oncology, German Oncology Center, 4108 Limassol, Cyprus.

Publikováno v: Cancers [Cancers (Basel)] 2022 Nov 16; Vol. 14 (22). Date of Electronic Publication: 2022 Nov 16.

Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group.

Autor: Fountzilas E; Second Department of Medical Oncology, Euromedica General Clinic of Thessaloniki, Gravias 5, 54645, Thessaloniki, Greece. elenafou@gmail.com.; European University Cyprus, Engomi, Cyprus. elenafou@gmail.com., Lampaki S; Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece., Koliou GA; Department of Biostatistics, Hellenic Cooperative Oncology Group, Athens, Greece., Koumarianou A; Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Levva S; Department of Medical Oncology, Bioclinic of Thessaloniki, Thessaloniki, Greece.; Department of Medical Oncology, Interbalkan Medical Center, Thessaloniki, Greece., Vagionas A; Oncology Department, General Hospital of Kavala, Kavala, Greece., Christopoulou A; Medical Oncology Unit, S. Andrew Hospital, Patras, Greece., Laloysis A; Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece., Psyrri A; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Binas I; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Mountzios G; Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece., Kentepozidis N; Department of Medical Oncology, 251 Airforce General Hospital, Athens, Greece., Kotsakis A; Department of Oncology, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Larissa, Greece., Saloustros E; Department of Oncology, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Larissa, Greece., Boutis A; First Department of Clinical Oncology, Theagenio Hospital, Thessaloniki, Greece., Nikolaidi A; Oncology Department, MITERA Hospital, Athens, Greece., Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.; Aristotle University of Thessaloniki, Thessaloniki, Greece.; German Oncology Center, Limassol, Cyprus., Georgoulias V; University of Crete, Rethymnon, Greece., Chrysanthidis M; First Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Kotteas E; Oncology Unit GPP, Sotiria General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Vo H; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tsiatas M; Department of Oncology, Athens Medical Center, Athens, Greece., Res E; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece., Linardou H; Fourth Oncology Department, Metropolitan Hospital, Piraeus, Greece., Daoussis D; Department of Internal Medicine, Division of Rheumatology, University of Patras Medical School, Patras University Hospital, Rion, Greece., Bompolaki I; Oncology Department, General Hospital of Chania, Crete, Greece., Andreadou A; Third Department of Medical Oncology, Theagenio Hospital, Thessaloniki, Greece., Papaxoinis G; Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece., Spyratos D; Pulmonary Department, Lung Cancer Oncology Unit, Aristotle University of Thessaloniki, G. Papanicolaou Hospital, Thessaloniki, Greece., Gogas H; First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Syrigos KN; Oncology Unit GPP, Sotiria General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Bafaloukos D; First Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Feb; Vol. 71 (2), pp. 327-337. Date of Electronic Publication: 2021 Jun 23.

Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece.

Autor: Papaxoinis G; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Athanasiadis A; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Sgouros J; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Visvikis A; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Drizou M; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Kontopodis E; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Koumarianou A; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Stojanovska S; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Aravantinos G; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Korantzis I; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Ioannou A; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Varthalitis I; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Doufexis D; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Nikolaou M; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Lypas G; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Bompolaki I; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Christopoulou A; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Liontos M; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Tsoukalas N; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Mauri D; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Xenidis N; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Katsaounis P; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Oikonomopoulos G; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece., Boukovinas I; Hellenic Society of Medical Oncology (HeSMO), Athens, Greece.

Publikováno v: Journal of oncology [J Oncol] 2020 Sep 19; Vol. 2020, pp. 5304516. Date of Electronic Publication: 2020 Sep 19 (Print Publication: 2020).